# Stentit

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stentit

- Industry: Biopolymers
- Headquarters: Eindhoven, Netherlands
- Website: www.stentit.com
- Total disclosed funding: $1.9M
- Latest round: Seed (Apr 24, 2022)
- Investors on record: 3

## About

Based in Eindhoven, Netherlands, and co-founded in 2017 by BART SANDERS, Stentit B.V., dba Stentit, is a regenerative medical devices manufacturer for cardio-related issues. In April 2022, Stentit B.V., led by its CEO Bart Sanders, raised EUR 1.8 million in seed funding from new investors NextGen Ventures, BOM Brabant Ventures, and the Ten Cate Investeringsmaatschappij.

The company provides a healthcare platform offering solutions for endovascular treatment based on regenerative stent technology supporting patients suffering from cardiovascular diseases.

The company intends to use the funds raised in April 2022 to expand the development and manufacturing of regenerative stents for peripheral applications.

## Funding rounds

- Seed, Apr 24, 2022, $1.9M — NextGen Ventures, BOM Brabant Ventures, Ten Cate Investeringsmaatschappij

## Investors

- NextGen Ventures — Seed
- BOM Brabant Ventures (https://capitalatlas.ai/funds/bom-brabant-ventures) — Seed
- Ten Cate Investeringsmaatschappij — Seed